Depression and Diabetes Control Trial - DDCT

Forschungsinstitut der Diabetes-Akademie Bad Mergentheim0 个研究点目标入组 213 人开始时间: 2017年2月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Age between 18 and 70
•- Diabetes mellitus type 1 or type 2
•- Diabetes duration = 1 year
•- Suboptimal glycaemic control (HbA1c > 7,5%)
•- Elevated depressive symptoms (CES-D score = 16) and/or elevated diabetes distress (PAID score = 40)
•- Sufficient language skills
•- Written informed consent

•- Severe major depressive disorder according to ICD-10
•- Current psychiatric and/or psychotherapeutic treatment
•- Current antidepressive medical treatment
•- Suicidal ideation
•- Acute mental disorder of the following type: schizophrenia or other psychotic disorder, bipolar disorder, severe eating disorder (anorexia nervosa, bulimia nervosa), substance use disorder
•- History of personality disorder
•- Severe somatic illnesses: dialysis-dependent nephropathy, acute cancer, severe heart disease (NYHA III - IV), severe neurologic illness (e. g. MS, dementia), severe autoimmune disease
•- Terminal illness
•- Bedriddenness
•- Guardianship

发起方

Forschungsinstitut der Diabetes-Akademie Bad Mergentheim